Marianne Camilla B.
- Country
- Denmark
- Department
- Nyremedicinsk afdeling, Nordsjællands Hospital Hillerød
Research Overview
- DAN-WAR-D - Danish Warfarin-Dialysis Study: Safety and efficacy of warfarin in patients with atrial fibrillation on dialysis -A nationwide parallel-group open randomized clinical trial
- Evaluation of Prophylactic Amoxicillin/Clavulanic Acid or Clindamycin in Preventing Bloodstream Infections in Hemodialysis Patients with Central Venous Catheters
- A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects with End Stage Kidney Disease Undergoing Dialysis
Data & Insights
Has run more than one trial at 5 of 201 partner sites.
Specializations
Cardiovascular and Renal Medicine
The investigator specializes in treating patients with end-stage kidney disease (ESKD) and associated cardiovascular complications, with particular focus on atherosclerotic cardiovascular disease in dialysis patients. Their research encompasses innovative therapeutic approaches for managing cardiovascular risk in renal patients.
- End-stage kidney disease management
- Cardiovascular complications in dialysis
- Atherosclerotic disease treatment
Their work extends to studying inflammatory markers and their role in cardiovascular outcomes among dialysis patients.
Infection Prevention and Control
The investigator focuses on preventing and treating bloodstream infections in hemodialysis patients, particularly those using central venous catheters. Their expertise includes developing prophylactic strategies for infection prevention in renal patients undergoing dialysis treatment.
- Blood infection prevention
- Antibiotic prophylaxis protocols
- Vascular access management
Their research addresses critical aspects of infection control in hemodialysis settings.
Anticoagulation Management
The investigator has particular interest in anticoagulation therapy for dialysis patients with atrial fibrillation. Their expertise includes evaluating the safety and efficacy of warfarin treatment in this specific patient population.
- Atrial fibrillation management
- Anticoagulation safety
- Dialysis-specific treatment protocols
Their work contributes to optimizing anticoagulation strategies for complex renal patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.